Santaballa A - Search Results

1

Long-term results after combined modality treatment for non-metastatic osteosarcoma.

Aparicio J, Segura A, Montalar J, Garcerá S, Oltra A, Santaballa A, Yuste A, Pastor M, Munárriz B. Aparicio J, et al. Among authors: santaballa a. Med Oncol. 1999 Dec;16(4):255-60. doi: 10.1007/BF02785871. Med Oncol. 1999. PMID: 10618688 Clinical Trial.

2

ESHAP is an active regimen for relapsing Hodgkin's disease.

Aparicio J, Segura A, Garcerá S, Oltra A, Santaballa A, Yuste A, Pastor M. Aparicio J, et al. Among authors: santaballa a. Ann Oncol. 1999 May;10(5):593-5. doi: 10.1023/a:1026454831340. Ann Oncol. 1999. PMID: 10416011 Free article. Clinical Trial.

3

Cisplatin plus vinorelbine for patients with advanced head and neck squamous cell carcinoma.

Segura A, Pastor M, Santaballa A, Yuste A, López P, Aparicio J. Segura A, et al. Among authors: santaballa a. Oncologist. 2000;5(2):177-8. doi: 10.1634/theoncologist.5-2-177. Oncologist. 2000. PMID: 10794811 Free article. Clinical Trial. No abstract available.

4

Hepatic resection in breast cancer metastases: should it be considered standard treatment?

Díaz R, Santaballa A, Munárriz B, Calderero V. Díaz R, et al. Among authors: santaballa a. Breast. 2004 Jun;13(3):254-8. doi: 10.1016/j.breast.2003.11.001. Breast. 2004. PMID: 15177433 Review.

5

[BRCA1 and BRCA2 mutations in patients with familial breast cancer].

Bolufer P, Munárriz B, Santaballa A, Velasco E, Lerma E, Barragán E. Bolufer P, et al. Among authors: santaballa a. Med Clin (Barc). 2005 Jan 15;124(1):10-2. doi: 10.1157/13070435. Med Clin (Barc). 2005. PMID: 15683621 Spanish.

6

Cost-benefit analysis of a follow-up program in patients with breast cancer: a randomized prospective study.

Oltra A, Santaballa A, Munárriz B, Pastor M, Montalar J. Oltra A, et al. Among authors: santaballa a. Breast J. 2007 Nov-Dec;13(6):571-4. doi: 10.1111/j.1524-4741.2007.00506.x. Breast J. 2007. PMID: 17983398 Clinical Trial.

7

Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study.

Antón A, Ruiz A, Plazaola A, Calvo L, Seguí MA, Santaballa A, Muñoz M, Sánchez P, Miguel A, Carrasco E, Lao J, Camps J, Alfaro J, Antolín S, Cámara MC. Antón A, et al. Among authors: santaballa a. Ann Oncol. 2011 Jan;22(1):74-79. doi: 10.1093/annonc/mdq317. Epub 2010 Jul 5. Ann Oncol. 2011. PMID: 20603435 Free article. Clinical Trial.

8

Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience.

Díaz R, Munárriz B, Santaballa A, Palomar L, Montalar J. Díaz R, et al. Among authors: santaballa a. Med Oncol. 2012 Mar;29(1):16-24. doi: 10.1007/s12032-010-9785-8. Epub 2010 Dec 31. Med Oncol. 2012. PMID: 21193967

9

SNPs and taxane toxicity in breast cancer patients.

Bosó V, Herrero MJ, Santaballa A, Palomar L, Megias JE, de la Cueva H, Rojas L, Marqués MR, Poveda JL, Montalar J, Aliño SF. Bosó V, et al. Among authors: santaballa a. Pharmacogenomics. 2014;15(15):1845-58. doi: 10.2217/pgs.14.127. Pharmacogenomics. 2014. PMID: 25495407

10

SEOM clinical guidelines in gestational trophoblastic disease (2017).

Santaballa A, García Y, Herrero A, Laínez N, Fuentes J, De Juan A, Rodriguez Freixinós V, Aparicio J, Casado A, García-Martinez E. Santaballa A, et al. Clin Transl Oncol. 2018 Jan;20(1):38-46. doi: 10.1007/s12094-017-1793-0. Epub 2017 Nov 17. Clin Transl Oncol. 2018. PMID: 29149431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters